The National Heart, Lung, and Blood Institute (NHLBI) has stopped early a major clinical trial of the risks and benefits of combined estrogen and progestin in healthy menopausal women due to an increased risk of invasive breast cancer. This page serves as a database of links to sites that explain the study results.